Patent 8466115 was granted and assigned to Zoetis on June, 2013 by the United States Patent and Trademark Office.
The invention recites spirocyclic isoxazoline derivatives of Formula (V.1), Formula (V.2), Formula (V.1.1), and Formula (1)